Stockscreener 앱 받기
0.65%
전일 마감가:
$24.60
열려 있는:
$24.68
하루 거래량:
36.99M
Relative Volume:
0.93
시가총액:
$140.77B
수익:
$63.83B
순이익/손실:
$10.77B
주가수익비율:
13.17
EPS:
1.88
순현금흐름:
$12.44B
1주 성능:
-4.33%
1개월 성능:
+1.89%
6개월 성능:
-5.13%
1년 성능:
-13.79%
1일 변동 폭
$24.51
$24.88
1주일 범위
$24.51
$25.89
52주 변동 폭
$20.91
$30.43
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
24.76 | 139.86B | 63.83B | 10.77B | 12.44B | 1.88 |
|
LLY
Lilly Eli Co
|
732.58 | 656.17B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
177.17 | 422.54B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
210.40 | 367.30B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
126.55 | 244.83B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.12 | 207.84B | 63.43B | 16.42B | 14.72B | 6.49 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer's Golden Cross Signals Strength: How to Play the Stock - TradingView
Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034 - GlobeNewswire Inc.
Stock Analysis | Pfizer OutlookNavigating Mixed Signals in a Volatile Market - AInvest
Advanced analytics toolkit walkthrough for Pfizer Inc.Market Trend Review & Stepwise Trade Signal Implementation - Newser
Should FDA Approval of Updated COVID Vaccine for Vulnerable Groups Prompt a Closer Look at Pfizer (PFE)? - simplywall.st
Is Pfizer Inc. trending in predictive chart modelsRecession Risk & Real-Time Market Trend Scan - Newser
Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine - MSN
Relative strength of Pfizer Inc. in sector analysisMarket Risk Summary & Fast Gain Swing Alerts - Newser
Price momentum metrics for Pfizer Inc. explainedPortfolio Value Report & AI Powered Market Trend Analysis - Newser
Developing predictive dashboards with Pfizer Inc. dataEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-08-30 04:48:26 - Newser
Chart overlay techniques for tracking Pfizer Inc.Weekly Investment Recap & Smart Money Movement Tracker - Newser
Pfizer Sued Over Depo-Provera Brain Tumor Risks - Law360
UPC sees rising small molecule litigation with Pfizer in the hot seat - Life Sciences Intellectual Property Review
Measuring Pfizer Inc.’s beta against major indicesMarket Rally & Smart Investment Allocation Tips - Newser
Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com
Moderna and Freshfields win against BioNTech and Pfizer at UK Court of Appeal - JUVE Patent
Using flow based indicators on Pfizer Inc.Market Activity Report & Smart Swing Trading Techniques - Newser
Is It Too Late to Sell Pfizer Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Layoff Tracker: Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ - BioSpace
How to read the order book for Pfizer Inc.2025 Top Decliners & Daily Profit Focused Screening - Newser
Pfizer Shares Drop 1.87% on $1.07B Top Volume as Patent Cliff and Medicare Reforms Loom R&D Setbacks Add Pressure Amid Cost-Cutting Hopes - AInvest
Pfizer Inc. - Britannica
COVID-19 Vaccines: Pfizer Arguments To Keep EUA Failed To Persuade US FDA’s Prasad - insights.citeline.com
Is Pfizer Stock A Sell On Its Severely Limited Covid Shots? - Investor's Business Daily
At $25 Is Pfizer Stock Deep Value Or A Falling Knife? - Forbes
Can Pfizer's Cost Cuts And New Drugs Offset Upcoming Headwinds? - Barchart.com
Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds? - The Globe and Mail
Pfizer: A 6% Dividend Yield That Pays You To Stay Defensive (NYSE:PFE) - Seeking Alpha
Time To Buy Pfizer Stock? - Trefis
Prasad explains why FDA revoked Pfizer’s Covid vaccine EUA for children - Endpoints News
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.92%
자본화:
|
볼륨(24시간):